Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.24 (
mitogen-activated protein kinase
)
95,810
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Microtubule-associated protein 2 kinase
(
MAP kinase
), which exists in several forms, is a protein serine/threonine kinase that participates in a growth factor-activated protein kinase cascade in which it activates a ribosomal protein S6 kinase (pp90rsk) while being regulated itself by a cytoplasmic factor (
MAP kinase
activator). Experiments with recombinant
MAP kinase
,
ERK2
, purified from Escherichia coli in a nonactivated form revealed a self-catalyzed phosphate incorporation into both tyrosine and threonine residues. Another
MAP kinase
,
ERK1
, purified from insulin-stimulated cells also autophosphorylated on tyrosine and threonine residues. Autophosphorylation of
ERK2
correlated with its autoactivation, although both autophosphorylation and autoactivation were slow compared to that occurring in the presence of
MAP kinase
activator. Therefore, we propose that autophosphorylation is probably involved in the
MAP kinase
activation process in vitro, but it may not be sufficient for full activation. The specificity toward tyrosine and threonine residues indicates that the MAP kinases
ERK1
and
ERK2
are members of a group of kinases with specificity for tyrosine as well as serine and threonine residues.
...
PMID:Microtubule-associated protein 2 kinases, ERK1 and ERK2, undergo autophosphorylation on both tyrosine and threonine residues: implications for their mechanism of activation. 171 80